Rational design of potent sialidase-based inhibitors of influenza virus replication

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,642 · see citing works

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution

Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,535 · see citing works

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623 · see citing works

Influenza virus M2 protein has ion channel activity

Pinto, L. H., Holsinger, L. J., & Lamb, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90452-i · Cited by 1,233 · see citing works

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution

Varghese, J. N., Laver, W. G., & Colman, P. M. (1983) · Nature · doi:10.1038/303035a0 · Cited by 891 · see citing works

The molecular basis of the specific anti‐influenza action of amantadine.

Hay, A. J., Wolstenholme, A. J., Skehel, J. J., & Smith, M. H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04038.x · Cited by 847 · see citing works

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d-N-acetylneuraminate) substrate

Potier, M., Mameli, L., Bélisle, M., Dallaire, L., & Melançon, S. B. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90362-2 · Cited by 816 · see citing works

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

Colman, P. M., Varghese, J. N., & Laver, W. G. (1983) · Nature · doi:10.1038/303041a0 · Cited by 806 · see citing works

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

Palese, P., Tobita, K., Ueda, M., & Compans, R. W. (1974) · Virology · doi:10.1016/0042-6822(74)90276-1 · Cited by 788 · see citing works

A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors

Henderson, P. J. F. (1972) · Biochemical Journal · doi:10.1042/bj1270321 · Cited by 526 · see citing works

Sialic acids and their role as biological masks

Schauer, R. (1985) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(85)90112-4 · Cited by 522 · see citing works

Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families

Hayden, F. G., Belshe, R. B., Clover, R. D., Hay, A. J., Oakes, M. G., & Soo, W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212502 · Cited by 416 · see citing works

Crystallographic refinement by simulated annealing

Brünger, A. T. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90211-2 · Cited by 405 · see citing works

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

Varghese, J. N., McKimm‐Breschkin, J. L., Caldwell, J. B., Kortt, A. A., & Colman, P. M. (1992) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340140302 · Cited by 402 · see citing works

Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae

Gottschalk, A. (1957) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(57)90389-x · Cited by 360 · see citing works

ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS

Hirst, G. K. (1942) · The Journal of Experimental Medicine · doi:10.1084/jem.76.2.195 · Cited by 316 · see citing works

The Molecular Biology of Influenza Virus Pathogenicity

Klenk, H. D., & ROTT, R. (1988) · Advances in virus research · doi:10.1016/s0065-3527(08)60520-5 · Cited by 315 · see citing works

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

Burmeister, W. P., Ruigrok, R. W. H., & Cusack, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05026.x · Cited by 314 · see citing works

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

Meindl, P., Bodo, G., Palese, P., Schulman, J., & Tuppy, H. (1974) · Virology · doi:10.1016/0042-6822(74)90080-4 · Cited by 287 · see citing works

Plaque inhibition assay for drug susceptibility testing of influenza viruses

Hayden, F. G., Cote, K. M., & Douglas, R. G. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.5.865 · Cited by 279 · see citing works

Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2·2 Å resolution

Varghese, J. N., & Colman, P. M. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80068-6 · Cited by 231 · see citing works

Using linear and non-linear regression to fit biochemical data

Leatherbarrow, R. J. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90295-m · Cited by 204 · see citing works

Evidence for a sialosyl cation transition‐state complex in the reaction of sialidase from influenza virus

Chong, A. K. J., PEGG, M. S., Taylor, N. R., & von Itzstein, M. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17055.x · Cited by 178 · see citing works

[Enzymatic effect of the influenza virus].

KLENK, E., Faillard, H., & Lempfrid, H. (1955) · PubMed · Cited by 157 · see citing works

Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position

Holzer, C. T., von Itzstein, M., Jin, B., Pegg, M. S., Stewart, W. P., & Wu, W.-Y. (1993) · Glycoconjugate Journal · doi:10.1007/bf00731185 · Cited by 155 · see citing works

Über die enzymatische Wirkung von Influenzavirus

Klenk, E., Faillard, H., & Lempfrid, H. (1955) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1955.301.1-2.235 · Cited by 146 · see citing works

Structural carbohydrates in the liver

McIntyre, N. R. (1984) · Gut · doi:10.1136/gut.25.10.1126-a · Cited by 140 · see citing works

Viral and Bacterial Neuraminidases

Drzeniek, R. (1972) · Modern aspects of electrochemistry · doi:10.1007/978-3-642-65444-2_2 · Cited by 134 · see citing works

The Thucydides Syndrome

Langmuir, A. D., Worthen, T. D., Solomon, J., Ray, C. G., & Petersen, E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510173131618 · Cited by 102 · see citing works

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

Stoof, J. C., Booij, J., Drukarch, B., & Wolters, E. C. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90634-g · Cited by 95 · see citing works

Uptake, Metabolism and Excretion of Orally and Intravenously Administered, Double‐Labeled N‐GIycoloylneuraminic Acid and Single‐Labeled 2‐Deoxy‐2,3–dehydro‐N‐acetylneuraminic Acid in Mouse and Rat

NÖHLE, U., Beau, J., & Schauer, R. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06815.x · Cited by 68 · see citing works

MUCINS AND MUCOIDS IN RELATION TO INFLUENZA VIRUS ACTION

Burnet, F. M. (1948) · Immunology and Cell Biology · doi:10.1038/icb.1948.39 · Cited by 66 · see citing works

Influenza virus sialidase: effect of calcium on steady-state kinetic parameters

Chong, A. K. J., Pegg, M. S., & von Itzstein, M. (1991) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(91)90526-6 · Cited by 64 · see citing works

Structure of the lysosomal neuraminidase–β-galactosidase–carboxypeptidase multienzymic complex

Potier, M., Michaud, L., Tranchemontagne, J., & Thauvette, L. (1990) · Biochemical Journal · doi:10.1042/bj2670197 · Cited by 55 · see citing works

Neuraminidase

Colman, P. M. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0811-9_4 · Cited by 46 · see citing works

Geometries of functional group interactions in enzyme-ligand complexes: Guides for receptor modelling

Tintelnot, M., & Andrews, P. R. (1989) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf01590996 · Cited by 45 · see citing works

Dependence of the Activity of an Influenza Virus Neuraminidase Upon Ca2+

Dimmock, N. J. (1971) · Journal of General Virology · doi:10.1099/0022-1317-13-3-481 · Cited by 28 · see citing works

Complete metal ion requirement of influenza virus N1 neuraminidases

Carroll, S. M., & Paulson, J. C. (1982) · Archives of Virology · doi:10.1007/bf01314879 · Cited by 16 · see citing works

Biological roles of glycans

Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635 · see citing works

Chemical Glycobiology

Bertozzi, C. R., & Kiessling, A. L. L. (2001) · Science · doi:10.1126/science.1059820 · Cited by 1,942 · see citing works

Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function

Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816 · see citing works

How were new medicines discovered?

Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812 · see citing works

Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation

Jones, G., Willett, P., & Glen, R. C. (1995) · Journal of Molecular Biology · doi:10.1016/s0022-2836(95)80037-9 · Cited by 1,548 · see citing works

Approved Antiviral Drugs over the Past 50 Years

Clercq, E. D., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,443 · see citing works

Virtual screening of chemical libraries

Shoichet, B. K. (2004) · Nature · doi:10.1038/nature03197 · Cited by 1,425 · see citing works

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

Li, C., Lim, S., Xia, W., Lee, H., Chan, L.-C., Kuo, C., Khoo, K., Chang, S.-S., Cha, J., Kim, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms12632 · Cited by 1,100 · see citing works

Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity

Kim, C. U., Lew, W., Williams, M. A., Liu, H., Zhang, L., Swaminathan, S., Bischofberger, N., Chen, M. S., Mendel, D. B., Tai, C. Y., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963036t · Cited by 1,100 · see citing works

Neuraminidase Inhibitors for Influenza

Moscona, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050740 · Cited by 1,090 · see citing works

Mechanisms of enzymatic glycoside hydrolysis

McCarter, J. D., & Withers, G. (1994) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(94)90271-2 · Cited by 883 · see citing works

3D-QSAR in Drug Design - A Review

Verma, J. K., Khedkar, V. M., & Coutinho, E. C. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232260 · Cited by 832 · see citing works

From carbohydrate leads to glycomimetic drugs

Ernst, B., & Magnani, J. L. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2852 · Cited by 819 · see citing works

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design

Russell, R. J. M., Haire, L. F., Stevens, D. J., Collins, P. J., Lin, Y. P., Blackburn, G. M., Hay, A. J., Gamblin, S. J., & Skehel, J. J. (2006) · Nature · doi:10.1038/nature05114 · Cited by 822 · see citing works

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial

Nicholson, K., Aoki, F., Osterhaus, A., Trottier, S., Carewicz, O., Mercier, C., Rode, A., Kinnersley, N., & Ward, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02288-1 · Cited by 785 · see citing works

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

Kiso, M., Mitamura, K., Sakai‐Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., & Kawaoka, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16934-1 · Cited by 785 · see citing works

Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing

Patil, R., Das, S., Stanley, A., Yadav, L., Sudhakar, A., & Varma, A. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012029 · Cited by 766 · see citing works

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections

Hayden, F. G., Osterhaus, A. D. M. E., Treanor, J. J., Fleming, D. M., Aoki, F. Y., Nicholson, K. G., Bohnen, A. M., Hirst, H. M., Keene, O., & Wightman, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371302 · Cited by 762 · see citing works

Influenza virus neuraminidase inhibitors

Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11433-8 · Cited by 734 · see citing works

Glycosidase inhibitors: update and perspectives on practical use

Asano, N. (2003) · Glycobiology · doi:10.1093/glycob/cwg090 · Cited by 717 · see citing works

The war against influenza: discovery and development of sialidase inhibitors

von Itzstein, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2400 · Cited by 705 · see citing works

Influenza: lessons from past pandemics, warnings from current incidents

Horimoto, T., & Kawaoka, Y. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1208 · Cited by 695 · see citing works

Antiviral agents active against influenza A viruses

Clercq, E. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2175 · Cited by 670 · see citing works

Strategies in the design of antiviral drugs

Clercq, E. D. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 651 · see citing works

Asymmetric Activation

Mikami, K., Terada, M., Korenaga, T., Matsumoto, Y., Ueki, M., & Angelaud, R. (2000) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20001016)39:20 · Cited by 134 · see citing works

Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review

Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 631 · see citing works

Use of molecular docking computational tools in drug discovery

Stanzione, F., Giangreco, I., & Cole, J. C. (2021) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2021.01.004 · Cited by 649 · see citing works

In silico methods and tools for drug discovery

Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104851 · Cited by 614 · see citing works

Functional balance between haemagglutinin and neuraminidase in influenza virus infections

Wagner, R., Matrosovich, M. N., & Klenk, H. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.352 · Cited by 608 · see citing works

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials

Dobson, J., Whitley, R. J., Pocock, S., & Monto, A. S. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62449-1 · Cited by 598 · see citing works

Binding of Small-Molecule Ligands to Proteins: “What You See” Is Not Always “What You Get”

Mobley, D., & Dill, K. (2009) · Structure · doi:10.1016/j.str.2009.02.010 · Cited by 569 · see citing works

Diversity of Microbial Sialic Acid Metabolism

Vimr, E. R., Kalivoda, K. A., Deszo, E. L., & Steenbergen, S. M. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.1.132-153.2004 · Cited by 580 · see citing works

Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza: Randomized Controlled Trials for Prevention and Treatment

Hayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P., & Straus, S. E. (1999) · JAMA · doi:10.1001/jama.282.13.1240 · Cited by 550 · see citing works

Pandemic Threat Posed by Avian Influenza A Viruses

Horimoto, T., & Kawaoka, Y. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.129-149.2001 · Cited by 542 · see citing works

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

Collins, P. J., Haire, L. F., Lin, Y. P., Liu, J., Russell, R. J. M., Walker, P. A., Skehel, J. J., Martin, S. R., Hay, A. J., & Gamblin, S. J. (2008) · Nature · doi:10.1038/nature06956 · Cited by 538 · see citing works

In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705

Furuta, Y., Takahashi, K., Fukuda, Y., Kuno, M., Kamiyama, T., Kozaki, K., Nomura, N., Egawa, H., Minami, S., Watanabe, Y., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.977-981.2002 · Cited by 503 · see citing works

Ensemble Docking in Drug Discovery.

Amaro, R., Baudry, J., Chodera, J., Demir, Ö., McCammon, J., Miao, Y.-L., & Smith, J. C. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.02.038 · Cited by 435 · see citing works

Exploitation of glycosylation in enveloped virus pathobiology

Watanabe, Y., Bowden, T. A., Wilson, I. A., & Crispin, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.012 · Cited by 485 · see citing works

Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation

Chen, J., Lee, K. H., Steinhauer, D. A., Stevens, D. J., Skehel, J. J., & Wiley, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81771-7 · Cited by 476 · see citing works

Sialic Acids in Molecular and Cellular Interactions

Kelm, S., & Schauer, R. (1997) · International review of cytology · doi:10.1016/s0074-7696(08)62127-0 · Cited by 458 · see citing works

On the Nature of the Multivalency Effect: A Thermodynamic Model

Kitov, P. I., & Bundle, D. R. (2003) · Journal of the American Chemical Society · doi:10.1021/ja038223n · Cited by 445 · see citing works

Drug resistance in influenza A virus: the epidemiology and management

Hussain, M., Galvin, H. D., Haw, T. Y., Nutsford, A. N., & Husain, M. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s105473 · Cited by 441 · see citing works

Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus

Gubareva, L. V., Matrosovich, M. N., Brenner, M. K., Bethell, R. C., & Webster, R. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/314440 · Cited by 432 · see citing works

Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses

Suzuki, Y. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.399 · Cited by 424 · see citing works

Emerging principles for the therapeutic exploitation of glycosylation

Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N., & Dwek, R. A. (2014) · Science · doi:10.1126/science.1235681 · Cited by 447 · see citing works

Structure, function and metabolism of sialic acids

Traving, C., & Schauer, R. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050258 · Cited by 411 · see citing works

Successful Applications of Computer Aided Drug Discovery: Moving Drugs from Concept to the Clinic

Talele, T. T., Khedkar, S. A., & Rigby, A. C. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232251 · Cited by 413 · see citing works

Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802

He, G. Z., Massarella, J. W., & Ward, P. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937060-00003 · Cited by 412 · see citing works

Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract

Flerlage, T., Boyd, D. F., Meliopoulos, V., Thomas, P. G., & Schultz‐Cherry, S. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00542-7 · Cited by 406 · see citing works

Asymmetric organocatalysis: an enabling technology for medicinal chemistry

Han, B., He, X., Liu, Y., He, G., Peng, C. Y., & Li, J. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00196a · Cited by 405 · see citing works

An Overview of Drug Discovery and Development

Berdigaliyev, N., & Aljofan, M. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0307 · Cited by 409 · see citing works

Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.

Taylor, G. L., Crennell, S. J., Takimoto, T., & Portner, A. (2000) · Nature Structural Biology · doi:10.1038/81002 · Cited by 392 · see citing works

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance

McKimm‐Breschkin, J. L. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12047 · Cited by 392 · see citing works

Balanced Hemagglutinin and Neuraminidase Activities Are Critical for Efficient Replication of Influenza A Virus

Mitnaul, L. J., Matrosovich, M. N., Castrucci, M. R., Tuzikov, A. B., Bovin, N. V., Kobasa, D., & Kawaoka, Y. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6015-6020.2000 · Cited by 389 · see citing works

Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug Design

Davis, A. M., Teague, S. J., & Kleywegt, G. J. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200539 · Cited by 386 · see citing works

The sweet spot: defining virus–sialic acid interactions

Stencel-Baerenwald, J., Reiß, K., Reiter, D. M., Stehle, T., & Dermody, T. S. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3346 · Cited by 385 · see citing works

BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design

Babu, Y. S., Chand, P., Bantia, S., Kotian, P. L., Dehghani, A., El-Kattan, Y. A., Lin, T., Hutchison, T. L., Elliott, A. J., Parker, C. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002679 · Cited by 385 · see citing works

Antivirals and antiviral strategies

Clercq, E. D. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro975 · Cited by 371 · see citing works

Animal Models for Influenza Virus Pathogenesis and Transmission

Bouvier, N. M., & Lowen, A. C. (2010) · Viruses · doi:10.3390/v20801530 · Cited by 364 · see citing works

Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

Monto, A. S., McKimm‐Breschkin, J. L., Macken, C. A., Hampson, A. W., Hay, A. J., Klimov, A. I., Tashiro, M., Webster, R. G., Aymard, M., Hayden, F. G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01339-05 · Cited by 364 · see citing works

Pressure induced amorphization of materials

Sharma, S. M., & Sikka, S. K. (1996) · Progress in Materials Science · doi:10.1016/0079-6425(95)00006-2 · Cited by 349 · see citing works

Recent advances in computer-aided drug design

Song, C. M., Lim, S. J., & Tong, J. (2009) · Briefings in Bioinformatics · doi:10.1093/bib/bbp023 · Cited by 344 · see citing works

Dihydropyrancarboxamides Related to Zanamivir: A New Series of Inhibitors of Influenza Virus Sialidases. 1. Discovery, Synthesis, Biological Activity, and Structure−Activity Relationships of 4-Guanidino- and 4-Amino-4H-pyran-6-carboxamides

Smith, P. W., Sollis, S. L., Howes, P. D., Cherry, P. C., Starkey, I. D., Cobley, K. N., Weston, H. E., Scicinski, J. J., Merritt, A., Whittington, A. R., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970374b · Cited by 342 · see citing works

Keynote review: Structural biology and drug discovery

Congreve, M., Murray, C. W., & Blundell, T. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03484-7 · Cited by 338 · see citing works

Influenza virus neuraminidase: Structure, antibodies, and inhibitors

Colman, P. M. (1994) · Protein Science · doi:10.1002/pro.5560031007 · Cited by 334 · see citing works

Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy

Clercq, E. D., & Field, H. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706446 · Cited by 334 · see citing works

Structure-based drug design: progress, results and challenges

Verlinde, C. L. M. J., & Hol, W. G. J. (1994) · Structure · doi:10.1016/s0969-2126(00)00060-5 · Cited by 331 · see citing works

Structures of influenza A proteins and insights into antiviral drug targets

Das, K., Aramini, J. M., Ma, L.-C., Krug, R. M., & Arnold, E. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1779 · Cited by 330 · see citing works

Synthesis of chiral pharmaceutical intermediates by biocatalysis

Patel, R. N. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.10.031 · Cited by 329 · see citing works

What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs?

Böhm, H., & Klebe, G. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199625881 · Cited by 328 · see citing works

Exploration of the Sialic Acid World

Schauer, R., & Kamerling, J. P. (2018) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/bs.accb.2018.09.001 · Cited by 323 · see citing works

Resistance of influenza viruses to neuraminidase inhibitors — a review

McKimm‐Breschkin, J. L. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00103-0 · Cited by 320 · see citing works

Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections

(1998) · The Lancet · doi:10.1016/s0140-6736(98)10190-3 · Cited by 351 · see citing works

Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion

Russell, R. J. M., Kerry, P. S., Stevens, D. J., Steinhauer, D. A., Martin, S. R., Gamblin, S. J., & Skehel, J. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807142105 · Cited by 314 · see citing works

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

Woods, J. M., Bethell, R. C., Coates, J. A., Healy, N., Hiscox, S. A., Pearson, B. A., Ryan, D., Ticehurst, J. R., Tilling, J., & Walcott, S. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1473 · Cited by 312 · see citing works

Microbial recognition of target-cell glycoconjugates

Karlsson, K. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80054-9 · Cited by 310 · see citing works

Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol

Ленева, И. А., Russell, R. J. M., Boriskin, Y. S., & Hay, A. J. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.10.009 · Cited by 300 · see citing works

Assignment of the Absolute Configuration of Polyfunctional Compounds by NMR Using Chiral Derivatizing Agents

Seco, J. M., Quiñoá, E., & Riguera, R. (2012) · Chemical Reviews · doi:10.1021/cr2003344 · Cited by 294 · see citing works

Structure−Activity Relationship Studies of Novel Carbocyclic Influenza Neuraminidase Inhibitors

Kim, C. U., Lew, W., Williams, M. A., Wu, H., Zhang, L., Chen, X., Escarpe, P. A., Mendel, D. B., Laver, W. G., & Stevens, R. C. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980162u · Cited by 292 · see citing works

Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir

McKimm‐Breschkin, J. L., Trivedi, T., Hampson, A. W., Hay, A. J., Klimov, A. I., Tashiro, M., Hayden, F. G., & Zambon, M. C. F. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2264-2272.2003 · Cited by 291 · see citing works

Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza

Hayden, F. G. (1996) · JAMA · doi:10.1001/jama.1996.03530280047035 · Cited by 291 · see citing works

Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms

Kirchmair, J., Williamson, M. J., Tyzack, J. D., Tan, L., Bond, P. J., Bender, A., & Glen, R. C. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200542m · Cited by 295 · see citing works

Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution

Zeng, Q., Langereis, M. A., van Vliet, A. L. W., Huizinga, E. G., & de Groot, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800502105 · Cited by 289 · see citing works

Synthesis and Biological Activity of Natural Aminocyclopentitol Glycosidase Inhibitors: Mannostatins, Trehazolin, Allosamidins, and Their Analogues

Berecibar, A., Grandjean, C., & Siriwardena, A. H. (1999) · Chemical Reviews · doi:10.1021/cr980033l · Cited by 289 · see citing works

Biochemical engineering of the N-acyl side chain of sialic acid: biological implications

Keppler, O. T., Horstkorte, R., Pawlita, M., Schmidt, C., & Reutter, W. G. (2001) · Glycobiology · doi:10.1093/glycob/11.2.11r · Cited by 286 · see citing works

Classification of Water Molecules in Protein Binding Sites

Barillari, C., Taylor, J., Viner, R., & Essex, J. W. (2007) · Journal of the American Chemical Society · doi:10.1021/ja066980q · Cited by 285 · see citing works

Novel Chemical Space Exploration via Natural Products

Rosén, J., Gottfries, J., Mureşan, S., Backlund, A., & Oprea, T. I. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801514w · Cited by 284 · see citing works

Antiviral Drugs

Balfour, H. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401608 · Cited by 283 · see citing works

Docking Screens for Novel Ligands Conferring New Biology

Irwin, J. J., & Shoichet, B. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b02008 · Cited by 281 · see citing works

Next generation 3D pharmacophore modeling

Schaller, D., Šribar, D., Noonan, T., Deng, L., Nguyen, T. N., Pach, S., Machalz, D., Bermúdez, M., & Wolber, G. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1468 · Cited by 276 · see citing works

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus Infections

Monto, A. S., Fleming, D., Henry, D. C., de Groot, R., Mäkelä, M. J., Klein, T., Elliott, M., Keene, O. N., & Man, C. Y. (1999) · The Journal of Infectious Diseases · doi:10.1086/314904 · Cited by 275 · see citing works

Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery

Muhammed, M. T., & Aki, E. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220922103109 · Cited by 269 · see citing works

Transient virus infection and multiple sclerosis

Atkins, G. J., McQuaid, S., Morris-Downes, M. M., Galbraith, S. E., Amor, S., Cosby, S. L., & Sheahan, B. J. (2000) · Reviews in Medical Virology · doi:10.1002/1099-1654(200009/10)10:5 · Cited by 36 · see citing works

Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase

Xu, X., Zhu, X., Dwek, R. A., Stevens, J., & Wilson, I. A. (2008) · Journal of Virology · doi:10.1128/jvi.00959-08 · Cited by 262 · see citing works

Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments

Shivatare, S. S., Shivatare, V. S., & Wong, C. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01032 · Cited by 260 · see citing works

Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection

Mendel, D. B., Tai, C. Y., Escarpe, P. A., Li, W., Sidwell, R. W., Huffman, J. H., Sweet, C., Jakeman, K. J., Merson, J. R., Lacy, S. A., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.640 · Cited by 256 · see citing works

Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase

Colman, P. M., Hoyne, P. A., & Lawrence, M. C. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.2972-2980.1993 · Cited by 255 · see citing works

The structural basis for an essential subunit interaction in influenza virus RNA polymerase

OBAYASHI, E., Yoshida, H., Kawai, F., Shibayama, N., Kawaguchi, A., Nagata, K., Tame, J. R. H., & Park, S. (2008) · Nature · doi:10.1038/nature07225 · Cited by 254 · see citing works

Influenza neuraminidase

Air, G. M. (2011) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00304.x · Cited by 247 · see citing works

Glycosidase inhibition: assessing mimicry of the transition state

Gloster, T. M., & Davies, G. J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b915870g · Cited by 246 · see citing works

Influenza Virus Sialidase - A Drug Discovery Target

von Itzstein, M. (2011) · Springer eBooks · doi:10.1007/978-3-7643-8927-7 · Cited by 27 · see citing works

Advances in influenza virus sialidase inhibitors

Niu, Y., Cao, X., & Ye, X. (2007) · Lanzhou University Institutional Repository · Cited by 1 · see citing works

Sialidase as a target for inhibitors of influenza virus replication

Bethell, R. C., & Smith, P. W. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.10.1501 · Cited by 11 · see citing works

Design and Synthesis of Sialidase Inhibitors for Influenza Virus Infections

Rich, J., Gehle, D., & von Itzstein, M. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00107-0 · Cited by 10 · see citing works

Sialidases: structures, biological significance and therapeutic potential

Taylor, G. L. (1996) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(96)80014-5 · Cited by 223 · see citing works